Réaction #299

ord-96727602adb24b28af9c737e24f7315c

Équation de réaction

CC(=O)Nc1cnc(Br)cn1
CC(=O)Nc1cnc(Br)cn1
CN1CCNCC1
CN1CCNCC1
CC(=O)Nc1cnc(N2CCN(C)CC2)cn1
CC(=O)Nc1cnc(N2CCN(C
Rendement 79.5%

Solvants

Conditions de réaction

Température
120°CELSIUS

Mode opératoire

1-methylpiperazine (2.318 g, 23.14 mmol), N-(5-bromopyrazin-2-yl)acetamide (1 g, 4.63 mmol), tri-tert-butylphosphine (1.873 g, 9.26 mmol), tris(dibenzylideneacetone)dipalladium (0.085 g, 0.09 mmol) and potassium 2-methylpropan-2-olate (1.039 g, 9.26 mmol) were suspended in DMF (9.26 ml) and sealed into a microwave tube. The reaction was heated to 120 °C for 40 minutes in the microwave reactor and cooled to RT. The mixture was diluted with methanol and acidified with HCl, then the solution was purified by ion exchange chromatography, using an SCX column. The desired product was eluted from the column using 7M NH3/MeOH and pure fractions were evaporated to dryness to afford N-(5-(4-methylpiperazin-1-yl)pyrazin-2-yl)acetamide (0.866 g, 80 %) as a dark oil. Used without further purification.

Source

750 AstraZeneca ELN dataset